Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - TAX PROVISION
Tax Provision EBS - Emergent BioSolutions Inc.
29.3 M
LAST VALUE
-40.76%
2 YEAR CAGR
9.28%
5 YEAR CAGR
8.38%
10 YEAR CAGR